Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy

Photodynamic therapy (PDT) is a photochemistry based treatment modality that involves the generation of cytotoxic species through the interactions of a photosensitizer molecule with light irradiation of an appropriate wavelength. PDT is an approved therapeutic modality for several cancers globally and in several cases has proved to be effective where traditional treatments have failed. The key parameters that determine PDT efficacy are 1. the photosensitizer (nature of the molecules, selectivity, and macroscopic and microscopic localization etc.), 2. light application (wavelength, fluence, fluence rate, irradiation regimes etc.) and 3. the microenvironment (vascularity, hypoxic regions, stromal tissue density, molecular heterogeneity etc.). Over the years, several groups aimed to monitor and manipulate the components of these critical parameters to improve the effectiveness of PDT treatments. However, PDT is still misconstrued to be a surface treatment primarily due to the limited depths of light penetration. In this review, we present the recent advances, strategies and perspectives in PDT approaches, particularly in cancer treatment, that focus on increasing the 'damage zone' beyond the reach of light in the body. This is enabled by a spectrum of approaches that range from innovative photosensitizer excitation strategies, increased specificity of phototoxicity, and biomodulatory approaches that amplify the biotherapeutic effects induced by photodynamic action. Along with the increasing depth of understanding of the underlying physical, chemical and physiological mechanisms, it is anticipated that with the convergence of these strategies, the clinical utility of PDT will be expanded to a powerful modality in the armamentarium for the management of cancer.

[1]  V. Fingar,et al.  Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[2]  Mamta Khurana,et al.  Simultaneous Two-photon Excitation of Photofrin in Relation to Photodynamic Therapy , 2006, Photochemistry and photobiology.

[3]  D. Kessel,et al.  Enhanced Efficacy of Photodynamic Therapy via a Sequential Targeting Protocol , 2014, Photochemistry and photobiology.

[4]  G. Xu,et al.  Gold nanorod enhanced two-photon excitation fluorescence of photosensitizers for two-photon imaging and photodynamic therapy. , 2014, ACS applied materials & interfaces.

[5]  Tayyaba Hasan,et al.  Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. , 2010, Cancer research.

[6]  Ying Gu,et al.  Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy. , 2013, Journal of medicinal chemistry.

[7]  D. Cramb,et al.  Near‐Infrared Two‐Photon Excitation of Protoporphyrin IX: Photodynamics and Photoproduct Generation ¶ , 2000, Photochemistry and photobiology.

[8]  Wei Chen,et al.  Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. , 2006, Journal of nanoscience and nanotechnology.

[9]  A. Colasanti,et al.  Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model. , 2004, Acta biochimica Polonica.

[10]  M. Calin,et al.  Photodynamic therapy in oncology , 2006 .

[11]  Michael R Hamblin,et al.  Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. , 1997, British Journal of Cancer.

[12]  H. Barr,et al.  Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitizer , 1989, Lasers in Medical Science.

[13]  John F. Callan,et al.  Extending the tissue penetration capability of conventional photosensitisers: a carbon quantum dot-protoporphyrin IX conjugate for use in two-photon excited photodynamic therapy. , 2013, Chemical communications.

[14]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[15]  Alexander M Seifalian,et al.  Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. , 2009, Nanomedicine.

[16]  S. Jacques Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.

[17]  U. Schmidt-Erfurth,et al.  Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.

[18]  P. Vandenabeele,et al.  DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[19]  Tayyaba Hasan,et al.  Pretreatment photosensitizer dosimetry reduces variation in tumor response. , 2006, International journal of radiation oncology, biology, physics.

[20]  J E Moulder,et al.  The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. , 1993, Journal of neurosurgery.

[21]  H. Oppelaar,et al.  Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy , 2000, International journal of cancer.

[22]  Tayyaba Hasan,et al.  Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates , 2014, Proceedings of the National Academy of Sciences.

[23]  T. Hasan,et al.  The "Nano" World in Photodynamic Therapy. , 2014, Austin journal of nanomedicine & nanotechnology.

[24]  Amirhossein Ahmadi,et al.  The effects of combined treatment with ionizing radiation and indocyanine green-mediated photodynamic therapy on breast cancer cells. , 2012, Journal of photochemistry and photobiology. B, Biology.

[25]  Yong Zhang,et al.  Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.

[26]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[27]  Johan Axelsson,et al.  Cerenkov emission induced by external beam radiation stimulates molecular fluorescence. , 2011, Medical physics.

[28]  H J Sterenborg,et al.  Photodynamic therapy with pulsed light sources: a theoretical analysis , 1996, Physics in medicine and biology.

[29]  T. Hasan,et al.  Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.

[30]  Hazel A. Collins,et al.  Two-photon absorption and the design of two-photon dyes. , 2009, Angewandte Chemie.

[31]  Stefan Andersson-Engels,et al.  Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.

[32]  Cristina Kurachi,et al.  In vitro and in vivo evaluation of the induced PDT response using a femtosecond laser , 2009, World Congress of the International Photodynamic Association.

[33]  C. Heusser,et al.  Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Timothy Solberg,et al.  X-ray excited ZnS:Cu,Co afterglow nanoparticles for photodynamic activation , 2014 .

[35]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[36]  M. Korbelik,et al.  Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. , 2006, International immunopharmacology.

[37]  L. Zitvogel,et al.  Decoding Cell Death Signals in Inflammation and Immunity , 2010, Cell.

[38]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[39]  Chin-Tu Chen,et al.  Enhanced Plasmonic Resonance Energy Transfer in Mesoporous Silica-Encased Gold Nanorod for Two-Photon-Activated Photodynamic Therapy , 2014, Theranostics.

[40]  Barbara W Henderson,et al.  Photodynamic therapy: a means to enhanced drug delivery to tumors. , 2003, Cancer research.

[41]  Mark Horn,et al.  The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs. , 2013, Translational oncology.

[42]  P. Choyke,et al.  Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies? , 2015, The Journal of Nuclear Medicine.

[43]  Michael R Hamblin,et al.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. , 2001, Cancer research.

[44]  J. Moan,et al.  Radiosensitization of tumours by porphyrins. , 2006, Cancer letters.

[45]  Michael R Hamblin,et al.  Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. , 2000, Cancer research.

[46]  Sabrina Oliveira,et al.  Nanobody-photosensitizer conjugates for targeted photodynamic therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[47]  T. Hasan,et al.  Verteporfin‐based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines , 2011, Lasers in Surgery and Medicine.

[48]  M W Berns,et al.  Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation. , 1985, Cancer research.

[49]  M. Korbelik,et al.  Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy , 2000, British Journal of Cancer.

[50]  V. Bykerk,et al.  Etanercept in the treatment of rheumatoid arthritis , 2007, Therapeutics and clinical risk management.

[51]  M. Teulade‐Fichou,et al.  Synthesis and characterization of glycoconjugated porphyrin triphenylamine hybrids for targeted two-photon photodynamic therapy. , 2014, The Journal of organic chemistry.

[52]  Mamta Khurana,et al.  Quantitative In Vitro Demonstration of Two‐Photon Photodynamic Therapy Using Photofrin® and Visudyne® , 2007, Photochemistry and photobiology.

[53]  T Nishisaka,et al.  Comparison of phototoxicity mechanism between pulsed and continuous wave irradiation in photodynamic therapy. , 1999, Journal of photochemistry and photobiology. B, Biology.

[54]  Tayyaba Hasan,et al.  The role of photodynamic therapy in overcoming cancer drug resistance , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[55]  Jonathan F. Lovell,et al.  Chemophototherapy: An Emerging Treatment Option for Solid Tumors , 2016, Advanced science.

[56]  Paola Taroni,et al.  Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.

[57]  Patrizia Agostinis,et al.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.

[58]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[59]  J. Moore,et al.  In vivo Expression of the Collagen-Related Heat Shock Protein HSP47, Following Hyperthermia or Photodynamic Therapy , 2001, Lasers in Medical Science.

[60]  T. Dougherty Photodynamic therapy. , 1993, Photochemistry and photobiology.

[61]  Michael R Hamblin,et al.  Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. , 2000, Gynecologic oncology.

[62]  Samuel Achilefu,et al.  Breaking the Depth Dependency of Phototherapy with Cerenkov Radiation and Low Radiance Responsive Nanophotosensitizers , 2015, Nature nanotechnology.

[63]  Vanderlei Salvador Bagnato,et al.  Necrosis response to photodynamic therapy using light pulses in the femtosecond regime , 2013, Lasers in Medical Science.

[64]  Brian Pogue,et al.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema , 2014, Journal of biomedical optics.

[65]  M L Yarmush,et al.  Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Anhe Wang,et al.  Bioluminescent microcapsules: applications in activating a photosensitizer. , 2013, Chemistry.

[67]  Zhuang Liu,et al.  Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics , 2013, Theranostics.

[68]  M. Berns,et al.  Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. , 1988, Journal of the National Cancer Institute.

[69]  Michael R Hamblin,et al.  Cationic photoimmunoconjugates between monoclonal antibodies and hematoporphyrin: selective photodestruction of ovarian cancer cells. , 1998, Applied optics.

[70]  G. Singh,et al.  Induction of Hsp60 by Photofrin-mediated photodynamic therapy. , 2001, Journal of photochemistry and photobiology. B, Biology.

[71]  Paras N. Prasad,et al.  Photosensitization of Singlet Oxygen via Two-Photon-Excited Fluorescence Resonance Energy Transfer in a Water-Soluble Dendrimer , 2005 .

[72]  A. Mantovani,et al.  IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. , 2003, Trends in immunology.

[73]  C. Poh,et al.  Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders. , 2012, Oral diseases.

[74]  M. Bentley,et al.  Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.

[75]  Sung Yong Choi,et al.  Bioluminescence-Activated Deep-Tissue Photodynamic Therapy of Cancer , 2015, Theranostics.

[76]  Chih-Ching Wu,et al.  Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets , 2003, Journal of cellular physiology.

[77]  J. Weinstein,et al.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.

[78]  B. Pogue,et al.  Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light , 1999, British Journal of Cancer.

[79]  S. Mordon,et al.  Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study. , 2016, Photodiagnosis and photodynamic therapy.

[80]  J. Woodhams,et al.  The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[81]  Bryan Q. Spring,et al.  A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways , 2015, Nature nanotechnology.

[82]  Gary T. Wang,et al.  Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. , 1990, Science.

[83]  J. Parrish,et al.  Therapeutic Uses of Light , 1985, Annals of the New York Academy of Sciences.

[84]  Barbara W Henderson,et al.  Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.

[85]  Ching-Wen Chen,et al.  Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy. , 2013, Biomaterials.

[86]  Erkinay Abliz,et al.  Novel applications of diagnostic X-rays in activating a clinical photodynamic drug: Photofrin II through X-ray induced visible luminescence from "rare-earth" formulated particles. , 2011, Journal of X-ray science and technology.

[87]  Antony K. Chen,et al.  Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA , 2008, Nucleic acids research.

[88]  Feng Liu,et al.  Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment. , 2015, Nano letters.

[89]  William R. Dichtel,et al.  Singlet oxygen generation via two-photon excited FRET. , 2004, Journal of the American Chemical Society.

[90]  K. Okkenhaug,et al.  Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. , 2003, Cancer research.

[91]  Smita Dayal,et al.  Quantum Dot-based Energy Transfer: Perspectives and Potential for Applications in Photodynamic Therapy , 2006, Photochemistry and photobiology.

[92]  H. Asanuma,et al.  Differences between cytotoxicity in photodynamic therapy using a pulsed laser and a continuous wave laser: study of oxygen consumption and photobleaching , 2004, Lasers in Medical Science.

[93]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[94]  B. Lovisa,et al.  Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion , 2012, Journal of cellular and molecular medicine.

[95]  Tayyaba Hasan,et al.  Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments , 2015, Cancer journal.

[96]  Sanjiv S Gambhir,et al.  Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.

[97]  David H. Kessel Photodynamic Therapy: Back to the Future , 2009 .

[98]  N. Lange,et al.  Combination of photodynamic therapy with anti-cancer agents. , 2008, Current medicinal chemistry.

[99]  D. Doiron,et al.  Photodynamic Therapy for Nonmelanoma Skin Cancer , 1989, Facial plastic surgery : FPS.

[100]  Stefan Andersson-Engels,et al.  Photodynamic therapy: superficial and interstitial illumination. , 2010, Journal of biomedical optics.

[101]  K. Nishio,et al.  Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor , 2007, Cancer science.

[102]  Mladen Korbelik,et al.  Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.

[103]  A. Meyers,et al.  PHOTODYNAMIC THERAPY — AN UPDATE ON CLINICAL APPLICATIONS , 2009 .

[104]  Muriel Barberi-Heyob,et al.  X-ray-Induced singlet oxygen activation with nanoscintillator-coupled porphyrins , 2013 .

[105]  Mark D. Savellano,et al.  Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. , 2012, Cancer letters.

[106]  Michael R Hamblin,et al.  Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer , 2000, British Journal of Cancer.

[107]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[108]  Daniel Rohrbach,et al.  Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report. , 2010, Optics express.

[109]  S. Mennel,et al.  Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 1) , 2007, Ophthalmologica.

[110]  G. Xu,et al.  Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy. , 2012, Nanoscale.

[111]  T. Hasan,et al.  Photoimmunotherapy of human ovarian carcinoma cells ex vivo. , 1991, Cancer research.

[112]  H. S. de Bruijn,et al.  EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[113]  J. Bhawalkar,et al.  Two-photon photodynamic therapy. , 1997, Journal of clinical laser medicine & surgery.

[114]  K. Camphausen,et al.  Nanoscintillator Conjugates as Photodynamic Therapy-Based Radiosensitizers: Calculation of Required Physical Parameters , 2009, Radiation research.

[115]  Michael R Hamblin,et al.  Cell Death Pathways in Photodynamic Therapy of Cancer , 2011, Cancers.

[116]  Britton Chance,et al.  Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. , 2004, Journal of the American Chemical Society.

[117]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[118]  Ulysses W. Sallum,et al.  Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. , 2009, Angewandte Chemie.

[119]  H. C. de Vijlder,et al.  Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. , 2012, Acta dermato-venereologica.

[120]  Tayyaba Hasan,et al.  Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. , 2016, Cancer research.

[121]  J. Borrell,et al.  Two-photon absorption in tetraphenylporphycenes: are porphycenes better candidates than porphyrins for providing optimal optical properties for two-photon photodynamic therapy? , 2007, Journal of the American Chemical Society.

[122]  Chunlei Zhu,et al.  Chemical molecule-induced light-activated system for anticancer and antifungal activities. , 2012, Journal of the American Chemical Society.

[123]  R. Supino,et al.  On the combination of photodynamic therapy with ionizing radiation. , 1999, Journal of photochemistry and photobiology. B, Biology.

[124]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[125]  Patrizio Salice,et al.  Assessment of water-soluble pi-extended squaraines as one- and two-photon singlet oxygen photosensitizers: design, synthesis, and characterization. , 2008, Journal of the American Chemical Society.

[126]  M. Korbelik,et al.  Role of Complement Anaphylatoxin C3a in Photodynamic Therapy-elicited Engagement of Host Neutrophils and Other Immune Cells , 2006, Photochemistry and photobiology.

[127]  A. Oseroff,et al.  Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.

[128]  Shannon M. Gallagher-Colombo,et al.  Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms. , 2015, Cancer research.

[129]  B. Wilson,et al.  Matrix metalloproteinase-based photodynamic molecular beacons for targeted destruction of bone metastases in vivo , 2016, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[130]  S. Mennel,et al.  Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 2) , 2007, Ophthalmologica.

[131]  Matthieu Réfrégiers,et al.  X-ray-induced radiophotodynamic therapy (RPDT) using lanthanide micelles: Beyond depth limitations , 2015, Nano Research.

[132]  H. S. de Bruijn,et al.  Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.

[133]  S. Bradforth,et al.  Photoluminescence of cerium fluoride and cerium-doped lanthanum fluoride nanoparticles and investigation of energy transfer to photosensitizer molecules. , 2014, Physical chemistry chemical physics : PCCP.

[134]  B. Wilson,et al.  Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation , 2007, Proceedings of the National Academy of Sciences.

[135]  Brian W. Pogue,et al.  Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody , 2013, PloS one.

[136]  J. E. Rogers,et al.  Light-Harvesting Chromophores with Metalated Porphyrin Cores for Tuned Photosensitization of Singlet Oxygen via Two-Photon Excited FRET , 2006 .

[137]  PhD Meike L. Schipper MD,et al.  Evaluation of Firefly Luciferase Bioluminescence Mediated Photodynamic Toxicity in Cancer Cells , 2006, Molecular Imaging and Biology.

[138]  Tayyaba Hasan,et al.  Prediction of Tumor Recurrence and Therapy Monitoring Using Ultrasound-Guided Photoacoustic Imaging , 2015, Theranostics.

[139]  J. Nicoud,et al.  Diketopyrrolopyrrole-porphyrin conjugates with high two-photon absorption and singlet oxygen generation for two-photon photodynamic therapy. , 2015, Angewandte Chemie.

[140]  W. Morgan,et al.  Non-targeted and Delayed Effects of Exposure to Ionizing Radiation: II. Radiation-Induced Genomic Instability and Bystander Effects In Vivo, Clastogenic Factors and Transgenerational Effects , 2003, Radiation research.

[141]  J Moan,et al.  Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. , 1995, Radiation Research.

[142]  S. Mordon,et al.  Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. , 2010, Photodiagnosis and photodynamic therapy.

[143]  Tayyaba Hasan,et al.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.

[144]  Paras N Prasad,et al.  Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.

[145]  M S Patterson,et al.  Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters. , 1997, Applied optics.

[146]  Paul M. Ripley,et al.  Photodynamic therapy for cancer of the pancreas , 2002, Gut.

[147]  Michael R Hamblin,et al.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference? , 2012, Israel journal of chemistry.

[148]  Dalong Ni,et al.  Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. , 2015, Angewandte Chemie.

[149]  H. S. de Bruijn,et al.  Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[150]  T. Hasan,et al.  Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. , 1994, British Journal of Cancer.

[151]  A. Joly,et al.  Investigation of water-soluble x-ray luminescence nanoparticles for photodynamic activation , 2008 .

[152]  R. Allison Photodynamic therapy: oncologic horizons. , 2014, Future oncology.

[153]  Mikhail Drobizhev,et al.  Synthesis, characterization and two-photon PDT efficacy studies of triads incorporating tumor targeting and imaging components , 2008, SPIE BiOS.

[154]  A. Melcher,et al.  Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. , 1999, Journal of immunology.

[155]  Petras Juzenas,et al.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. , 2008, Advanced drug delivery reviews.

[156]  B. Wilson,et al.  Facile synthesis of advanced photodynamic molecular beacon architectures. , 2010, Bioconjugate chemistry.

[157]  Christophe Dujardin,et al.  Modelling energy deposition in nanoscintillators to predict the efficiency of the X-ray-induced photodynamic effect. , 2015, Nanoscale.

[158]  L. Zitvogel,et al.  Molecular characteristics of immunogenic cancer cell death , 2008, Cell Death and Differentiation.

[159]  A. Schauer,et al.  Pulsed versus continuous wave excitation mechanisms in photodynamic therapy of differently graded squamous cell carcinomas in tumor-implanted nude mice , 2004, European Archives of Oto-Rhino-Laryngology.

[160]  B. Pogue,et al.  Vascular and cellular targeting for photodynamic therapy. , 2006, Critical reviews in eukaryotic gene expression.

[161]  Chin‐Hung Lai,et al.  A New Series of Quadrupolar Type Two‐Photon Absorption Chromophores Bearing 11, 12‐Dibutoxydibenzo[a,c]‐phenazine Bridged Amines; Their Applications in Two‐Photon Fluorescence Imaging and Two‐Photon Photodynamic Therapy , 2009 .

[162]  Joshua S Richman,et al.  Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer , 2015, Clinical Cancer Research.

[163]  T. Hasan,et al.  Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine Sarcomas , 1996, Photochemistry and photobiology.

[164]  P. Agostinis,et al.  ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[165]  Michael R Hamblin,et al.  A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy , 2006, British Journal of Cancer.

[166]  B W Henderson,et al.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.

[167]  B. Wilson,et al.  Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. , 2007, Journal of biomedical optics.

[168]  M S Patterson,et al.  The physics of photodynamic therapy. , 1986, Physics in medicine and biology.

[169]  J. Krosl,et al.  Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.

[170]  W. Denk,et al.  Two-photon laser scanning fluorescence microscopy. , 1990, Science.

[171]  B. Pogue,et al.  PDT Dose Parameters Impact Tumoricidal Durability and Cell Death Pathways in a 3D Ovarian Cancer Model , 2013, Photochemistry and photobiology.

[172]  Atsushi Ohashi,et al.  Strong two-photon absorption of self-assembled butadiyne-linked bisporphyrin. , 2004, Journal of the American Chemical Society.

[173]  Dominik J Naczynski,et al.  Rare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics. , 2014, Journal of materials chemistry. B.

[174]  Ying-xin Li,et al.  Generation of effective vaccines against liver cancer by using photodynamic therapy , 2009, Lasers in Medical Science.

[175]  M. Peev,et al.  Photodynamic therapy of experimental tumours with Zn(II)-phthalocyanine and pulsed laser irradiation , 1995, Lasers in Medical Science.

[176]  S. Jacques How tissue optics affect dosimetry of photodynamic therapy. , 2010, Journal of biomedical optics.

[177]  P Lenz,et al.  In vivo EXCITATION OF PHOTOSENSITIZERS BY INFRARED LIGHT , 1995, Photochemistry and photobiology.

[178]  L. Le Bodic,et al.  Neodymium-yttrium aluminium garnet laser destruction of nonsensitized and hematoporphyrin derivative-sensitized tumors. , 1983, Cancer research.

[179]  S. Carpenter,et al.  Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[180]  V. Jarý,et al.  Preliminary study on singlet oxygen production using CeF3:Tb3+@SiO2-PpIX , 2016 .

[181]  Michael R Hamblin,et al.  Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy , 2003, British Journal of Cancer.

[182]  W. Jerjes,et al.  Prospective evaluation of 110 patients following ultrasound-guided photodynamic therapy for deep seated pathologies. , 2011, Photodiagnosis and photodynamic therapy.

[183]  C J Gomer,et al.  Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. , 2000, Cancer research.

[184]  S. Gollnick Photodynamic therapy and antitumor immunity. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[185]  Mark D. Savellano,et al.  Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic Study , 2005, Clinical Cancer Research.

[186]  S. Gollnick,et al.  Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4 , 2009, The Journal of Immunology.

[187]  Yuriy Stepanenko,et al.  Extremely strong near-IR two-photon absorption in conjugated porphyrin dimers: quantitative description with three-essential-states model. , 2005, The journal of physical chemistry. B.

[188]  Bryan Q. Spring,et al.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[189]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.

[190]  Ahmed H. Elmenoufy,et al.  Nanocomposite-Based Photodynamic Therapy Strategies for Deep Tumor Treatment. , 2015, Small.

[191]  Tayyaba Hasan,et al.  Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success , 2016, Physics in medicine and biology.

[192]  P. Ogilby,et al.  Two-photon photosensitized production of singlet oxygen. , 2001, Journal of the American Chemical Society.

[193]  K. Soo,et al.  Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.

[194]  Aleksander Rebane,et al.  Blood-vessel closure using photosensitizers engineered for two-photon excitation , 2008 .

[195]  Mark D. Savellano,et al.  Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates¶ , 2003, Photochemistry and photobiology.

[196]  Tayyaba Hasan,et al.  Development and applications of photo-triggered theranostic agents. , 2010, Advanced drug delivery reviews.